GLP-1 receptor agonists, including semaglutide, have been associated with acute pancreatitis in postmarketing surveillance, though a definitive causal relationship has not been established
Route 2: Private MHRA-licensed prescriptions The MHRA licence allows private prescribing at BMI 30 or above, or BMI 27 to 29.9 if you have at least one weight-related comorbidity (a co-occurring health condition that justifies prescribing) 1,2
Should you have further questions or concerns about Zepbound, Semaglutide GLP-1, Wegovy, or Mounjaro, or if youre interested in starting a weight management regimen tailored to your unique needs, dont hesitate to reach out to us at Reliable MD
"I think ideally this medicine will be for people who haven't tried a weight loss drug yet," he says